Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequately Controlled Asthma”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03376932
What this trial is testing

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

Who this might be right for
Asthma
GlaxoSmithKline
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746687
What this trial is testing

JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

Who this might be right for
Asthma
Janssen Research & Development, LLC 440
Testing effectiveness (Phase 2)Study completedNCT01730027
What this trial is testing

Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

Who this might be right for
Asthma
Pulmagen Therapeutics 248
Large-scale testing (Phase 3)Study completedNCT01914757
What this trial is testing

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Who this might be right for
Asthma
AstraZeneca 2,508
Post-approval studies (Phase 4)Study completedNCT00264849
What this trial is testing

Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma

Who this might be right for
Asthma
Novartis 406
Testing effectiveness (Phase 2)WithdrawnNCT01458912
What this trial is testing

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

Who this might be right for
Asthma
Boehringer Ingelheim
Post-approval studies (Phase 4)Study completedNCT00329381
What this trial is testing

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Large-scale testing (Phase 3)Ended earlyNCT02902809
What this trial is testing

Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Who this might be right for
Inadequately Controlled Asthma
AstraZeneca 28
Testing effectiveness (Phase 2)WithdrawnNCT01458886
What this trial is testing

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone

Who this might be right for
Asthma
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT04048343
What this trial is testing

Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma

Who this might be right for
Severe Asthma
AstraZeneca 65
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Large-scale testing (Phase 3)Study completedNCT05202262
What this trial is testing

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

Who this might be right for
Asthma
AstraZeneca 645
Large-scale testing (Phase 3)Study completedNCT01155700
What this trial is testing

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 51
Large-scale testing (Phase 3)Study completedNCT02555683
What this trial is testing

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Who this might be right for
Asthma
Novartis Pharmaceuticals 894
Post-approval studies (Phase 4)Study completedNCT00691873
What this trial is testing

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Post-approval studies (Phase 4)Study completedNCT00760838
What this trial is testing

AZISAST Study: AZIthromycin in Severe ASThma Study

Who this might be right for
Asthma
University Hospital, Ghent 109
Testing effectiveness (Phase 2)Study completedNCT00930163
What this trial is testing

Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

Who this might be right for
Asthma
Genentech, Inc. 218
Testing effectiveness (Phase 2)Study completedNCT01603277
What this trial is testing

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Who this might be right for
Moderate-to-Severe Asthma
Humanigen, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT06977581
What this trial is testing

Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Who this might be right for
Asthma
Pfizer 252
Large-scale testing (Phase 3)Study completedNCT00046748
What this trial is testing

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 484
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation